2025 United Kingdom Adult And Pediatric Vaccines Market Revenue Opportunities Report
Description
The 2025 United Kingdom Adult And Pediatric Vaccines Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Adult and Pediatric Vaccines Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Adult and Pediatric Vaccines Market in the United Kingdom are GlaxoSmithKline (GSK), Pfizer, Merck & Co., and Sanofi. GSK, headquartered in London, is a global leader in vaccines including pediatric vaccines and innovative products like the shingles vaccine Shingrix, investing heavily in infectious disease vaccines. Pfizer, based in New York but significantly active in the UK, developed the pioneering mRNA COVID-19 vaccine Comirnaty, authorized for use in infants and adults, and also markets vaccines for pneumococcal infections and meningitis. Merck, recognized for vaccines such as Gardasil (HPV) and rotavirus, is another key global player with a strong presence in the UK immunization programs. Sanofi, headquartered in Paris, through Sanofi Pasteur, supplies influenza, polio, and combination childhood vaccines widely used in the UK.
These companies contribute significantly to the UK vaccination landscape by supplying routine immunizations protecting children and adults against a range of infectious diseases. GSK and Sanofi provide vaccines recommended by UK health authorities for pediatric vaccination schedules, including polio and combination vaccines like DTaP-IPV-Hib. Pfizer’s Comirnaty vaccine has been authorized extensively for pediatric COVID-19 immunization in the UK, covering infants from 6 months to older children. Merck’s vaccine products support broader infectious disease prevention, complementing efforts by UK public health to maintain high immunization coverage and respond to emerging viral threats. Together, these companies shape the UK’s vaccine market with strong R&D pipelines and comprehensive vaccine portfolios across age groups.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Adult and Pediatric Vaccines Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the Adult and Pediatric Vaccines Market in the United Kingdom are GlaxoSmithKline (GSK), Pfizer, Merck & Co., and Sanofi. GSK, headquartered in London, is a global leader in vaccines including pediatric vaccines and innovative products like the shingles vaccine Shingrix, investing heavily in infectious disease vaccines. Pfizer, based in New York but significantly active in the UK, developed the pioneering mRNA COVID-19 vaccine Comirnaty, authorized for use in infants and adults, and also markets vaccines for pneumococcal infections and meningitis. Merck, recognized for vaccines such as Gardasil (HPV) and rotavirus, is another key global player with a strong presence in the UK immunization programs. Sanofi, headquartered in Paris, through Sanofi Pasteur, supplies influenza, polio, and combination childhood vaccines widely used in the UK.
These companies contribute significantly to the UK vaccination landscape by supplying routine immunizations protecting children and adults against a range of infectious diseases. GSK and Sanofi provide vaccines recommended by UK health authorities for pediatric vaccination schedules, including polio and combination vaccines like DTaP-IPV-Hib. Pfizer’s Comirnaty vaccine has been authorized extensively for pediatric COVID-19 immunization in the UK, covering infants from 6 months to older children. Merck’s vaccine products support broader infectious disease prevention, complementing efforts by UK public health to maintain high immunization coverage and respond to emerging viral threats. Together, these companies shape the UK’s vaccine market with strong R&D pipelines and comprehensive vaccine portfolios across age groups.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
